SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001600132-18-000034
Filing Date
2018-03-15
Accepted
2018-03-15 16:30:00
Documents
75
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blph-12312017x10k.htm 10-K 2179833
2 EXHIBIT 23.1 blph-12312017x10kex231.htm EX-23.1 4436
3 EXHIBIT 31.1 blph-12312017x10kex311.htm EX-31.1 11974
4 EXHIBIT 31.2 blph-12312017x10kex312.htm EX-31.2 11979
5 EXHIBIT 32 blph-12312017x10kex32.htm EX-32 7911
12 indicationtablea01.jpg GRAPHIC 42479
  Complete submission text file 0001600132-18-000034.txt   7833473

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blph-20171231.xml EX-101.INS 1544678
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20171231.xsd EX-101.SCH 50654
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20171231_cal.xml EX-101.CAL 77076
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20171231_def.xml EX-101.DEF 233532
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20171231_lab.xml EX-101.LAB 667549
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20171231_pre.xml EX-101.PRE 396354
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 18692817
SIC: 2834 Pharmaceutical Preparations